Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
A Post Marketing Surveillance on Piqray in Korea |
Breast Cancer | Korea, Republic of | NCT05293470 | |
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN |
IC-MPGN | Phase3 | Argentina Brazil Canada Czechia France Germany India Israel Italy Japan Poland Spain Switzerland Turkey United Kingdom United States Vietnam View All |
NCT05755386 |
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission |
Non-radiographic Axial Spondyloarthritis | Phase4 | Belgium Brazil Colombia Czechia France Germany Hungary Israel Italy Malaysia Mexico Netherlands Philippines Poland Romania Thailand Turkey Vietnam View All |
NCT05622708 |
The Belgian REAL (BE.REAL) Registry |
Atherosclerotic Cardiovascular Disease | Belgium | NCT05726838 | |
A Study of Zigakibart in Adults With IgA Nephropathy |
IgA Nephropathy, Immunoglobulin A Nephropathy | Phase3 | Argentina Australia Belgium Brazil Canada China Croatia Czechia France Germany Greece India Israel Italy Japan Korea, Republic of Malaysia Mexico Spain Taiwan Turkey United Kingdom United States View All |
NCT05852938 |
A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy |
Achilles Tendinopathy | Phase2 | France Germany United Kingdom United States View All |
NCT05592990 |
A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration |
Age-Related Macular Degeneration | Phase2 | United Kingdom | NCT05230537 |
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) |
Atypical Hemolytic Uremic Syndrome | Phase3 | China Japan Spain Turkey United Kingdom View All |
NCT05935215 |
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. |
Lymphatic Malformations | Phase2, Phase3 | Australia Belgium France Germany Italy Spain United States View All |
NCT05948943 |
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines |
Chronic Inducible Urticaria | Phase3 | Argentina Australia Brazil Canada France Hong Kong Hungary India Israel Italy Japan Korea, Republic of Malaysia Poland Singapore Slovakia Spain Thailand Turkey United States Vietnam View All |
NCT05976243 |